×

7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase

  • US 8,354,416 B2
  • Filed: 06/04/2008
  • Issued: 01/15/2013
  • Est. Priority Date: 03/25/2005
  • Status: Expired due to Fees
First Claim
Patent Images

1. The compound which is 3-[2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-5-fluoro-4-methyl-N-(1-methylethyl)benzamide, or a pharmaceutically acceptable salt thereof.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×